WhiteLab Genomics
Xi Liu is a highly experienced bioinformatician with a strong background in analyzing transcriptomic and genomic data, currently working at WhiteLab Genomics since December 2021. Prior experience includes significant roles at the Station Biologique de Roscoff from January 2014 to December 2018, focusing on quality control, data assembly, functional annotation, and database construction. Xi Liu also served as a biostatistician and bioinformatician at the Laboratory of Mathematics and Modeling for a study on RNA-seq data in wheat, as well as at the French National Institute for Agricultural Research, analyzing wine juice characteristics. Earlier positions include R&D Engineer at Lamy Lutti and sensory analyst roles at Inserm and François Rabelais University, contributing to several sensory and product development studies. Academic credentials include a Master’s Degree from Montpellier II University and dual Master’s and Bachelor’s degrees from François Rabelais University in relevant fields.
This person is not in any offices
WhiteLab Genomics
WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload andvector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.